FAM
GRCL

Fred Alger Management’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Fred Alger Management’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-61,578
Closed -$177K – 501
2023
Q3 		$177K Sell
61,578
-34,234
-36% -$98.6K ﹤0.01% 409
2023
Q2 		$365K Buy
+95,812
New +$365K ﹤0.01% 410